Invesaro

Stocks CSBR Earnings

Earnings

Champions Oncology, Inc. (CSBR) earnings

Quarterly results of Champions Oncology, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when CSBR files with the SEC.

Next earnings date

Champions Oncology, Inc. is expected to report around December 14, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q1 FY2027

In Q1 FY2027 (ended July 31, 2026) Champions Oncology, Inc. reported revenue of $15.2M (+8.8% on the same quarter a year earlier) and a net loss of $426K.

Diluted earnings per share were -$0.03.

Filed with the SEC on September 11, 2026.

Revenue by quarter
Q2 25: $13.5M $13.5M Q2 25Q3 25: $17M $17M Q3 25Q4 25: $12.4M $12.4M Q4 25Q1 26: $14M $14M Q1 26Q2 26: $15M $15M Q2 26Q3 26: $16.6M $16.6M Q3 26Q4 26: $13.8M $13.8M Q4 26Q1 27: $15.2M $15.2M Q1 27
Net income by quarter
Q2 25: $728K $728K Q2 25Q3 25: $4.5M $4.5M Q3 25Q4 25: -$1.8M -$1.8M Q4 25Q1 26: -$466K -$466K Q1 26Q2 26: $268K $268K Q2 26Q3 26: -$279K -$279K Q3 26Q4 26: -$698K -$698K Q4 26Q1 27: -$426K -$426K Q1 27

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q1 FY2027July 31, 2026$15.2M+8.8%-$426K-$0.03
Q4 FY2026April 30, 2026$13.8M+12%-$698K-
Q3 FY2026January 31, 2026$16.6M-2.8%-$279K-$0.02
Q2 FY2026October 31, 2025$15M+11.5%$268K$0.02
Q1 FY2026July 31, 2025$14M--$466K-$0.03
Q4 FY2025April 30, 2025$12.4M--$1.8M-
Q3 FY2025January 31, 2025$17M-$4.5M$0.31
Q2 FY2025October 31, 2024$13.5M-$728K$0.05

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Champions Oncology, Inc.'s next earnings date?

Champions Oncology, Inc. is expected to report around December 14, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Champions Oncology, Inc.'s latest quarterly results?

For Q1 FY2027, which ended July 31, 2026, Champions Oncology, Inc. reported revenue of $15.2M and a net loss of $426K. The figures come from its filing with the SEC.

Is Champions Oncology, Inc.'s revenue growing?

Revenue in Q1 FY2027 was $15.2M, up 8.8% from $14M in the same quarter a year earlier.

Get an email when CSBR reports

Follow CSBR and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when CSBR files with the SEC.

Source: quarterly figures Champions Oncology, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Champions Oncology, Inc.